ROCCKWeight Loss Impact on Knee Health in Obese Adults
This study aims to evaluate how weight loss affects the health of your knees, specifically focusing on changes in cartilage strain and thickness over a period of 3 and 6 months, using MRI scans.
Weight Loss
Arthritis+13
+ Body Weight
+ Body Weight Changes
Treatment Study
Summary
Study start date: June 5, 2020
Actual date on which the first participant was enrolled.This study focuses on reducing obesity and its impact on knee cartilage. It aims to enroll 70 participants, divided into a weight loss group and a weight maintenance group. The study is designed for individuals aged 18 to 45 with a body mass index (BMI) between 29 and 40, who have no history of lower extremity injury or symptoms of osteoarthritis (OA). Participants must also have neutral knee alignment. The goal is to understand how weight loss might help reduce strain on knee cartilage, potentially improving care for those with obesity-related knee issues. Participants will be asked about their health history and their height and weight will be recorded to calculate their BMI. If they meet the study criteria, they will be invited to join. The study will use MRI scans to measure changes in cartilage thickness and strain at 3 and 6 months. This non-invasive method helps track the effects of weight loss on knee health. Participants will be informed of all risks involved before they decide to take part in the study.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.88 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Duke University Medical Center
Durham, United StatesOpen Duke University Medical Center in Google Maps